Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 13.55 is 88% above its 5-year average of 7.20, near the high end of its 5-year range (5.14–13.55).
As of the fiscal period ended Tuesday, June 30, 2026. 75.35% above its 12-month average of 7.73.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 13.55.
CURRENT RATIO
13.55
CURRENT RATIO AVG TTM
7.73
CURRENT RATIO AVG 3Y
7.55
CURRENT RATIO AVG 5Y
7.20
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+75.35%
CURRENT VS 3Y AVG
+79.63%
CURRENT VS 5Y AVG
+88.31%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+260.48%
vs the sector median at left
Aprea Therapeutics, Inc.
Market Cap
$7.87M
Current Ratio
13.55
TTM Avg
7.73
3Y Avg
7.55
5Y Avg
7.20
Market Cap
$7.75M
Current Ratio
5.86
TTM Avg
2.71
3Y Avg
2.06
5Y Avg
3.31
Market Cap
$7.46M
Current Ratio
14.52
TTM Avg
3.29
3Y Avg
11.30
5Y Avg
10.20
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aprea Therapeutics, Inc. (APRE) | $7.87M | 13.55 | 7.73 | 7.55 | 7.20 |
| Traws Pharma, Inc. (TRAW)vs › | $7.92M | 0.43 | 1.44 | 2.56 | 3.54 |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.75M | 5.86 | 2.71 | 2.06 | 3.31 |
| GT Biopharma, Inc. (GTBP)vs › | $8.04M | 2.61 | 2.11 | 2.42 | 2.17 |
| DataMEDS AI, Inc. (MEDS)vs › | $8.05M | 0.14 | 0.24 | 0.20 | 0.20 |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.67M | 7.10 | 3.48 | 3.83 | 5.25 |
| Mangoceuticals, Inc. (MGRX)vs › | $7.64M | 0.18 | 0.90 | 2.08 | 1.78 |
| HeartSciences Inc. (HSCS)vs › | $8.14M | 0.12 | 0.56 | 1.70 | 1.47 |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.46M | 14.52 | 3.29 | 11.30 | 10.20 |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.33M | 0.60 | 0.62 | 0.79 | 1.04 |
Current Ratio
13.55
Quick Ratio
13.55
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 13.55 |
| 2026-03-31 | 8.92 |
| 2025-12-31 | 5.63 |
| 2025-09-30 | 5.20 |
| 2025-06-30 | 5.34 |
| 2025-03-31 | 5.90 |
| 2024-12-31 | 7.01 |
| 2024-09-30 | 7.28 |
| 2024-06-30 | 9.55 |
| 2024-03-31 | 11.15 |
| 2023-12-31 | 5.14 |
| 2023-09-30 | 6.15 |
| 2023-06-30 | 7.25 |
| 2023-03-31 | 7.57 |
| 2022-12-31 | 9.42 |
| 2022-09-30 | 8.37 |
| 2022-06-30 | 5.27 |
| 2022-03-31 | 7.45 |
| 2021-12-31 | 7.73 |
| 2021-09-30 | 6.88 |
| 2021-06-30 | 6.73 |
| 2021-03-31 | 7.14 |
| 2020-12-31 | 6.03 |
| 2020-09-30 | 7.49 |
| 2020-06-30 | 7.88 |
| 2020-03-31 | 10.79 |
| 2019-12-31 | 14.68 |
| 2019-09-30 | 5.92 |
| 2019-06-30 | 10.87 |
| 2019-03-31 | 0.00 |
| 2018-12-31 | 13.56 |
| 2018-09-30 | 0.00 |
